Literature DB >> 2888730

Recognition of the galactose- or N-acetylgalactosamine-binding lectin of Entamoeba histolytica by human immune sera.

W A Petri1, M P Joyce, J Broman, R D Smith, C F Murphy, J I Ravdin.   

Abstract

Cure of amebic liver abscess is associated with resistance to recurrent invasive amebiasis and the development of a humoral and cell-mediated immune response. We determined whether human immune sera contain blocking antibody for the 170-kilodalton (kDa) galactose or N-acetylgalactosamine (Gal/GalNAc)-binding lectin of Entamoeba histolytica. By Western blot (immunoblot) of whole amebae subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis, all eight immune sera studied here prominently recognized a 170-kDa amebic protein. Western blot of the purified Gal/GalNAc lectin with pooled human immune sera (PHIS) confirmed that the 170-kDa band was the adherence lectin. Immunoprecipitation of [35S]methionine-metabolically-labeled amebae with the antilectin monoclonal antibody H8-5 and with PHIS demonstrated that the 170-kDa lectin was the major antigen recognized by PHIS. The in vitro adherence of E. histolytica trophozoites to CHO cells at 4 degrees C was inhibited by prior exposure of amebae to greater than or equal to 1.0% PHIS. The humoral response to the Gal/GalNAc-binding lectin of the parasite may contribute to the development of protective immunity against invasive amebiasis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2888730      PMCID: PMC260708          DOI: 10.1128/iai.55.10.2327-2331.1987

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

1.  Experimental amebiasis. III. A rapid in vitro assay for virulence of Entamoeba histolytica.

Authors:  C F Mattern; D B Keister; P A Caspar
Journal:  Am J Trop Med Hyg       Date:  1978-09       Impact factor: 2.345

2.  A new medium for the axenic cultivation of Entamoeba histolytica and other Entamoeba.

Authors:  L S Diamond; D R Harlow; C C Cunnick
Journal:  Trans R Soc Trop Med Hyg       Date:  1978       Impact factor: 2.184

3.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

4.  Antibody response in intestinal and extraintestinal amebiasis.

Authors:  I M Krupp
Journal:  Am J Trop Med Hyg       Date:  1970-01       Impact factor: 2.345

5.  The pathogenesis of experimentally induced amebic liver abscess in the gerbil (Meriones unguiculatus).

Authors:  K Chadee; E Meerovitch
Journal:  Am J Pathol       Date:  1984-10       Impact factor: 4.307

6.  Cytopathogenic mechanisms of Entamoeba histolytica.

Authors:  J I Ravdin; B Y Croft; R L Guerrant
Journal:  J Exp Med       Date:  1980-08-01       Impact factor: 14.307

7.  Role of adherence in cytopathogenic mechanisms of Entamoeba histolytica. Study with mammalian tissue culture cells and human erythrocytes.

Authors:  J I Ravdin; R L Guerrant
Journal:  J Clin Invest       Date:  1981-11       Impact factor: 14.808

8.  Adherence and ingestion of Escherichia coli serotype 055 by trophozoites of Entamoeba histolytica.

Authors:  R Bracha; D Mirelman
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

9.  Antigenicity of Entamoeba histolytica strain nih 200: a survey of clinically relevant antigenic components.

Authors:  A A Kettis; R Thorstensson; G Utter
Journal:  Am J Trop Med Hyg       Date:  1983-05       Impact factor: 2.345

10.  Isolation and characterization of actin from Entamoeba histolytica.

Authors:  I Meza; M Sabanero; F Cazares; J Bryan
Journal:  J Biol Chem       Date:  1983-03-25       Impact factor: 5.157

View more
  20 in total

1.  The cysteine-rich region of the Entamoeba histolytica adherence lectin (170-kilodalton subunit) is sufficient for high-affinity Gal/GalNAc-specific binding in vitro.

Authors:  D R Pillai; P S Wan; Y C Yau; J I Ravdin; K C Kain
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

2.  Immunoreactivity of Entamoeba histolytica antigens with sera from amoebic patients.

Authors:  R K Shandil; V K Vinayak
Journal:  Med Microbiol Immunol       Date:  1990       Impact factor: 3.402

3.  Intestinal invasion by Entamoeba histolytica.

Authors:  Shahram Solaymani-Mohammadi; William A Petri
Journal:  Subcell Biochem       Date:  2008

4.  Detection of Entamoeba histolytica immunoglobulins G and M to plasma membrane antigen by enzyme-linked immunosorbent assay.

Authors:  M A Sathar; B L Bredenkamp; V Gathiram; A E Simjee; T F Jackson
Journal:  J Clin Microbiol       Date:  1990-02       Impact factor: 5.948

5.  Neutralizing monoclonal antibody epitopes of the Entamoeba histolytica galactose adhesin map to the cysteine-rich extracellular domain of the 170-kilodalton subunit.

Authors:  B J Mann; C Y Chung; J M Dodson; L S Ashley; L L Braga; T L Snodgrass
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

6.  The tumor necrosis factor alpha-stimulating region of galactose-inhibitable lectin of Entamoeba histolytica activates gamma interferon-primed macrophages for amebicidal activity mediated by nitric oxide.

Authors:  R Séguin; B J Mann; K Keller; K Chadee
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

Review 7.  Adherence and cytotoxicity of Entamoeba histolytica or how lectins let parasites stick around.

Authors:  J J McCoy; B J Mann; W A Petri
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

Review 8.  Amebic infection in humans.

Authors:  Gourdas Choudhuri; Murali Rangan
Journal:  Indian J Gastroenterol       Date:  2012-08-19

9.  Role of the galactose lectin of Entamoeba histolytica in adherence-dependent killing of mammalian cells.

Authors:  L D Saffer; W A Petri
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

Review 10.  Host-pathogen interaction in amebiasis and progress in vaccine development.

Authors:  C D Huston; W A Petri
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-09       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.